Pick Biotech Winners Like A Pro: John McCamantSeeking AlphaThat would be a huge leg up for the stock, at another 100 points. TLSR: And the B-cell lymphomas are a great trail to follow. JM: Exactly. When Rituxin [rituximab] was in development, it was a …
Heart Failure Pacemaker Could Help Less Severe Cases Too – Medical News Today
Heart Failure Pacemaker Could Help Less Severe Cases TooMedical News TodayPatients with milder forms of heart failure may also benefit from having a pacemaker inserted, not only those with severe heart failure, researchers from the Karolinska Institute…
Pfizer to challenge Indian ruling overturning cancer drug patent – Economic Times
Pfizer to challenge Indian ruling overturning cancer drug patentEconomic TimesThe patent office's decision went to the heart of India's patent act, which says a patent cannot be granted for a drug unless changes make it significantly more effec…
Watch: Ill Wisconsin Child Gets Wish to Hunt, Kill a Bear
Kaitlynn Bessette, 11, shot a 335-pound bear as she waits for a heart and liver transplant.
Scituate teen receives life-saving lung transplant
Sixteen-year-old Jonathan Michaud has been facing the battle of his life over the past five weeks. As a cystic fibrosis patient, Jonathan has endured many hospital stays and health issues in his young life.
HHS recognizes Boston Children's kidney transplant program as a top transplant program
( Boston Children's Hospital ) The Department of Health and Human Services has recognized Boston Children's Hospital's Kidney Transplant Program as a national leader in its field. The program received a Silver Level Award at a Medal of Hono…
Boston Children's Kidney Transplant Program Recognized as a Top Transplant Program by U.S. Department of Health and …
Only Pediatric Program in New England to Receive AwardBOSTON, Oct. 5, 2012 /PRNewswire-USNewswire/ — The Department of Health and Human Services has recognized Boston Children's Hospital's Kidney Transplant Program as a national leader in its…
Breast Oncologists Incorporate New Treatments, Grapple With Ongoing … – OncLive
OncLiveBreast Oncologists Incorporate New Treatments, Grapple With Ongoing …OncLiveEverolimus, recently approved in estrogen receptor [ER]-positive metastatic breast cancer, is being tested in combination with trastuzumab in HER2-positive disease in …
Roche Faces New Foe as Boehringer Plans a Rituxan Copy – Bloomberg
Roche Faces New Foe as Boehringer Plans a Rituxan CopyBloombergRituxan, also know by its generic name rituximab, had 6 billion Swiss francs ($6.45 billion) in sales last year. Roche's patents on the medicine expire in 2018 in the U.S. and earlier i…
Swiss Stocks Extend 19-Month High After US Jobs Report – Bloomberg
Swiss Stocks Extend 19-Month High After US Jobs ReportBloombergLonza Group AG (LONN) slipped 2.6 percent to 49.29 francs. Lonza and Teva Pharmaceutical Industries Ltd. are still evaluating the path forward for a phase III trial of its rituximab generic…